KKR Q3 Profit Surges Past Estimates on Strong Credit Fundraising

KKR (NYSE: KKR) posted third-quarter results that exceeded Wall Street expectations, led by a surge in new capital, particularly within its credit segment and insurance operations. Their adjusted net income clocked in at $1.27 billion, or $1.41 per share, above the consensus estimate of $1.17 billion or $1.30 per share.

The company's shares reacted positively in pre-market trading, edging up nearly 3%, despite a general dip in U.S. futures markets. Still, the stock has shed almost 19% year-to-date as broader economic pressures linger.

Amid a tough climate for traditional private equity exits, KKR's leadership has been shifting gears. Co-CEOs Scott Nuttall and Joe Bae aim to grow assets under management to $1 trillion by 2030, branching out from classic buy-and-sell equity deals into diversified alternative assets.

In the quarter, fee-related earnings hit $1 billion, boosted by a substantial $43 billion in fresh fundraising. Notably, $27 billion of that came concentrated in credit products, highlighting a strategic pivot in response to higher interest rates that have made business sales less favorable.

Private equity firms like Blackstone (NYSE: BX) and Apollo Global Management (NYSE: APO) face similar headwinds, and KKR's fundraising efforts included a $17.5 billion North America-focused fund currently targeting $20 billion in commitments.

Performance in traditional private equity took a hit, with returns slipping to 2% from 5% in the previous quarter. Conversely, KKR's insurance arm, Global Atlantic, which accounts for roughly a third of its assets, saw operating earnings climb 28%, a bright spot amid the mixed results.

KKR's balance sheet strength from credit and insurance segments appears to offer some resistance against rate volatility, echoing commentary from market analysts on how asset managers with diversified balance sheets are better insulated these days.

In addition to institutional capital, KKR has expanded its offerings to high-net-worth retail investors through its K-Series funds, which have more than doubled in size from $14 billion to $29 billion over the past year.

Dry powder - the uninvested capital ready for deployment - stands at a hefty $126 billion. The firm has recently closed deals, including acquiring a majority stake in Healthcare Royalty Partners and securing a $2 billion investment from Japan Post Insurance Company. Notably, post-quarter, KKR joined forces with Apollo to invest $7 billion into Keurig Dr Pepper (NYSE: KDP).